| Schedule of extension warrants issued to affiliates |
Between
September 22, 2014, and August 16, 2016, the Company raised an aggregate principal amount of $6.0 million in Notes, which along
with of $317,000 of interest thereon, were converted on September 21, 2016 into 1,263,406 shares of Common Stock at $5.00 per
share. Of the $6.0 million of Notes sold by the Company, $5.3 million were purchased by directors, an officer and greater than
5% shareholders of the Company and converted into shares as follows.
| |
|
Principal
Investment
in
Convertible Notes
|
|
Interest
Earned
At
conversion
|
|
Shares
Issued
on
conversion
|
| RSJ
PE |
(1) |
$
2,100,000 |
|
122,200 |
|
444,454 |
| John
Pappajohn |
(2) |
1,600,000 |
|
52,500 |
|
290,498 |
| Tierney
Family Trust |
(3) |
640,000 |
|
46,600 |
|
137,328 |
| Follman
Family Trust |
(4) |
550,000 |
|
20,400 |
|
114,074 |
| Robin
Smith MD |
(5) |
100,000 |
|
3,900 |
|
20,776 |
| Geoffrey
Harris |
(6) |
10,000 |
|
300 |
|
2,058 |
| George
Carpenter |
(7) |
100,000 |
|
1,300 |
|
20,254 |
| Oman
Ventures |
(8) |
200,000 |
|
20,400 |
|
44,089 |
| |
|
$
5,300,000 |
|
267,600 |
|
1,073,531 |
| |
(1) |
RSJ PE is a greater
than 5% shareholder. Michal Votruba, a Director for Life Sciences for the RSJ/Gradus Fund, joined our Board on July 30, 2015. |
| |
(2) |
John Pappajohn is
a member of the Board. He purchased $1,600,000 of Notes of which $200,000 were assigned to four accredited investors on September
6, 2015. Approximately $10,400 of the total interest was attributable to such transferred Notes, resulting in an aggregate
of 42,084 shares being issued upon the conversion of such transferred Notes. |
| |
(3) |
Thomas Tierney is
a trustee of the Tierney Family Trust. Mr. Tierney originally joined the Board on February 25, 2013 and served as Chairman
of the Board from March 26, 2013 through his resignation on May 22, 2015. On September 29, 2016 Mr. Tierney rejoined the Board.
The Tierney Family Trust is a greater than 5% shareholder of the Company. |
| |
(4) |
Robert Follman is
a trustee of the Follman Family Trust and is a member of the Board. |
| |
(5) |
Dr. Robin Smith
is the Chairman of the Board. |
| |
(6) |
Geoffrey Harris
is a member of the Board and Chairman of the Audit Committee. |
| |
(7) |
George Carpenter
is the CEO of the Company. |
| |
(8) |
Mark & Jill
Oman are the beneficial owners of Oman Ventures and were greater than 5% shareholders of the Company. |
|